The short-term and long-term outcomes of the endoscopic resection for the superficial pharyngeal squamous cell carcinoma

Background and study aims: Early detection of superficial pharyngeal squamous cell carcinoma (SPSCC) using narrow-band imaging as well as the increasing use of ER for gastrointestinal cancers may increase the number of ER for SPSCC. The aims of this study were to clarify the feasibility of ER for SPSCC and its long-term outcomes.

Patients and methods: In total, 84 patients with 115 lesions were treated by endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) between March 2004 and August 2012. We retrospectively assessed the en bloc and R0 resection rates, complications, lymph node metastasis (LNM), local recurrence, metachronous pharyngeal and esophageal SCC, 5-year overall and cause-specific survival rates.

Results: Higher proportions of en bloc and R0 resection were achieved with ESD compared to EMR (en bloc 100 % vs. 60 %, P < 0.001; R0 59 % vs. 26 %, P < 0.005). There were no significant complications in both groups. None of the patients died from primary SPSCC during the median follow-up of 34 months (range, 3 – 115). LNM occurred in three patients and local recurrence was detected in seven patients (8.3 %) with eight lesions. Tumor thickness over 1000 μm (P < 0.005) and positive or inconclusive horizontal margins (P < 0.05) were significant risk factors for LNM and local recurrence, respectively. Twelve patients died because of co-existing clinical conditions. The 5-year overall and cause-specific survival rates were 80.7 % and 100 %, respectively.

Conclusions: ER for SPSCC is a feasible treatment with promising results. Tumor thickness over 1000 μm is a significant risk factor for LNM and positive or inconclusive horizontal margin is a risk factor for local recurrence.

• References

• 1 Muto M, Minashi K, Yano T et al. Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol 2010; 28: 1566-1572
• 2 Nonaka S, Saito Y. Endoscopic diagnosis of pharyngeal carcinoma by NBI. Endoscopy 2008; 40: 347-351
• 3 Inoue H, Takeshita K, Hori H et al. Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions. Gastrointest Endosc 1993; 39: 58-62
• 4 Ono H, Kondo H, Gotoda T et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut 2001; 48: 225-229
• 5 Kraus DH, Zelefsky MJ, Brock HA et al. Combined surgery and radiation therapy for squamous cell carcinoma of the hypopharynx. Otolaryngol Head Neck Surg 1997; 116: 637-641
• 6 Suzuki H, Saito Y, Oda I et al. Feasibility of endoscopic mucosal resection for superficial pharyngeal cancer: a minimally invasive treatment. Endoscopy 2010; 42: 1-7
• 7 Shimizu Y, Yamamoto J, Kato M et al. Endoscopic submucosal dissection for treatment of early stage hypopharyngeal carcinoma. Gastrointest Endosc 2006; 64: 255-259
• 8 Iizuka T, Kikuchi D, Hoteya S et al. Endoscopic submucosal dissection for treatment of mesopharyngeal and hypopharyngeal carcinomas. Endoscopy 2009; 41: 113-117
• 9 Iizuka T, Kikuchi D, Hoteya S et al. A new technique for pharyngeal endoscopic submucosal dissection: peroral countertraction (with video). Gastrointest Endosc 2012; 76: 1034-1038
• 10 Japanese Classification of Esophageal Cancer. 10th. edn. Tokyo, Japan: Kanehara; 2008: 12-13
• 11 Muto M, Satake H, Yano T et al. Long-term outcome of transoral organ-preserving pharyngeal ER for superficial pharyngeal cancer. Gastrointest Endosc 2011; 74: 477-484
• 12 Imai K, Tanaka M, Hasuike N et al. Feasibility of a “resect and watch” strategy with ER for superficial pharyngeal cancer. Gastrointest Endosc 2013; 78: 22-29
• 13 Taniguchi M, Watanabe A, Tsujie H et al. Predictors of cervical lymph node involvement in patients with pharyngeal carcinoma undergoing endoscopic mucosal resection. Auris Nasus Larynx 2011; 38: 710-717
• 14 Makuuchi H, Shimada H, Mizutani K et al. Analysis of long term follow up patients after endoscopic mucosal resection for early esophageal cancer: with special reference to metachronous multiple cancers [in Japanese, English abstract]. Stomach Intest 1996; 31: 1223-1233
• 15 Oyama T, Miyata Y, Okaniwa S et al. Local recurrence of esophageal squamous cell carcinoma after endoscopic esophageal mucosal resection [in Japanese, English abstract]. Stomach Intest 1996; 31: 1217-1222
• 16 Esaki M, Matsumoto T, Hirakawa K et al. Risk factors for local recurrence of superficial esophageal cancer after treatment by endoscopic mucosal resection. Endoscopy 2007; 39: 41-45
• 17 Okada K, Tsuchida T, Ishiyama A et al. Endoscopic mucosal resection and endoscopic submucosal dissection for en bloc resection of superficial pharyngeal carcinomas. Endoscopy 2012; 44: 556-564
• 18 Iizuka T, Kikuchi D, Hoteya S et al. Clinical advantage of endoscopic submucosal dissection over endoscopic mucosal resection for early mesopharyngeal and hypopharyngeal cancers. Endoscopy 2011; 43: 839-843
• 19 Satake H, Yano T, Muto M et al. Clinical outcome after ER for superficial pharyngeal squamous cell carcinoma invading the subepithelial layer. Endoscopy 2015; 47: 11-18
• 20 Oda I, Gotoda T, Sasako M et al. Treatment strategy after non-curative ER of early gastric cancer. Br J Surg 2008; 95: 1495-1500
• 21 Muto M, Hironaka S, Nakane M et al. Association of multiple Lugol voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. Gastrointest Endosc 2002; 56: 517-521